Skip to content

Merck announces plans for licensing Atripla widely in developing world

HIV incidence rising in older gay men in Holland, most men recently infected undiagnosed

Women experience rapid fall in genital secretion of HIV after starting antiretovirals, but 50% still potentially infectious

Merck cuts price of efavirenz for developing countries again

MODS TB test as sensitive as and three times faster than culturing in resource-limited settings

Cannabis may be safe and effective for HIV-related neuropathic pain

Highly effective vaccine might delay AIDS by twelve years, but postpone starting treatment by only three years

One in eight UK HIV clinicians say cost reduced ARV prescribing choices in 2006

Metabolic syndrome as common in HIV-negative as in HIV-positive individuals